Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.8 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |